IMpassion130研究：阿替利珠单抗联合白蛋白紫杉醇治疗晚期三阴性乳腺癌的疗效分析
IMpassion130：The Efficacy of Atezolizumab Plus Nab-Paclitaxel Treatment in Comparison With Nab-Paclitaxel Alone as First-Line Treatment of Advanced Triple-Negative Breast Cancer
IMpassion130研究：阿替利珠单抗联合白蛋白紫杉醇治疗晚期三阴性乳腺癌的疗效分析 |
| 评价者：杨梅, 文献合成者：沈博 |
IMpassion130：The Efficacy of Atezolizumab Plus Nab-Paclitaxel Treatment in Comparison With Nab-Paclitaxel Alone as First-Line Treatment of Advanced Triple-Negative Breast Cancer |
| |